RAREUltragenyx Pharmaceutical Inc.

$26.47

Is it safe?

Can RARE take a bad year?

The deepest fall in RARE's price history on file is −90%; it is −28% below its high today.

-3.34

Altman Z-score · distress below 1.8 · safe above 3 · distress zone, the model puts this in the bankruptcy range

Cash runway
0.6 years

Cash runway · burning $122M a quarter at the current rate

Annualised volatility
59%

Annualised volatility · roughly twice as jumpy as the market

Worst drawdown on file
−90%

Worst drawdown on file · −28% today

Details
Cash and short-term investments
$292M
EBITDA, trailing twelve months
−$495M
Operating profit, trailing twelve months
−$528M
Annualised volatilitytwo years of daily moves
59%
Worst drawdown on file
−90%
Below its 52-week high
−28%

Balance sheet from SEC filings; drawdown and volatility from end-of-day closes; Altman Z from the filed statements.